Antibody-Fab and -Fc features promote Mycobacterium tuberculosis restriction.
Patricia S Grace,Joshua M Peters,Jaimie Sixsmith,Richard Lu,Brooke A Fenderson,Andrew Vickers,Matthew D Slein,Edward B Irvine,Tanya McKitrick,Mo-Hui Wei,Richard D Cummings,Aaron Wallace,Lisa Cavacini,Alok K Choudhary,Megan K Proulx,Christopher Sundling,Gunilla Källenius,Rajko Reljic,Joel D. Ernst,Arturo Casadevall,Camille Locht,Abraham Pinter,Christopher M Sassetti,Bryan D Bryson,Sarah M Fortune,Galit Alter
DOI: https://doi.org/10.1101/2024.10.07.617070
2024-10-11
Abstract:Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis (TB), is a leading cause of death by an infectious disease globally, with no efficacious vaccine. Antibodies are implicated in Mtb control, but the mechanisms of antibody action remain poorly understood. We assembled a library of TB monoclonal antibodies (mAb) and screened for the ability to restrict Mtb in mice, identifying protective antibodies targeting known and novel antigens. To dissect the mechanism of mAb-mediated Mtb restriction, we optimized a protective lipoarabinomannan-specific mAb through Fc-swapping. In vivo analysis of these Fc-variants revealed a critical role for Fc-effector function in Mtb restriction. Restrictive Fc-variants altered distribution of Mtb across innate immune cells. Single-cell transcriptomics highlighted distinctly activated molecular circuitry within innate immune cell subpopulations, highlighting early activation of neutrophils as a key signature of mAb-mediated Mtb restriction. Therefore, improved antibody-mediated restriction of Mtb is associated with reorganization of the tissue-level immune response to infection and depends on the collaboration of antibody Fab and Fc.
Immunology